Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 32INDUSTRY 4NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3Other 1Gastrointestinal 1

Conditions

Immunoglobulin Light-chain Amyloidosis 2Purpura 1Nausea 1Multiple Myeloma 1Macroglossia 1Lymphadenopathy 1Hepatomegaly 1Gastrointestinal Hemorrhage 1Diarrhea 1Constipation 1Amyloidosis 1

Interventions

Cisplatin 118Radiotherapy 114Cyclophosphamide 93Paclitaxel 84Gemcitabine 74Carboplatin 67Filgrastim 60Doxorubicin 57Vincristine 56Etoposide 56Docetaxel 56Fluorouracil 51Cytarabine 41Prednisone 40Methotrexate 40Leucovorin 39Dexamethasone 37Capecitabine 36Irinotecan 35Rituximab 29Oxaliplatin 28Granulocyte Colony-Stimulating Factor 27Cetuximab 26Bevacizumab 26durvalumab 24Temozolomide 24Radiotherapy, Intensity-Modulated 24Peripheral Blood Stem Cell Transplantation 24Magnetic Resonance Spectroscopy 24Surgical Procedures, Operative 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × NETWORK × isatuximab × Clear all
NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed
43 enrolled 23 charts
GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT05123131 2025-07-08

Isa-RVD

Cancer Trials Ireland

Phase 2 Active not recruiting
54 enrolled
Plasma cell

Multiple Myeloma

NCT05066607 2024-03-06

IsAMYP

Intergroupe Francophone du Myelome

Phase 2 Unknown
46 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡